Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03775412
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
PVE | (1S)-1-CARBOXY-5-[(3-CARBOXYPROPANOYL)AMINO]- 8,9-DIHYDROXY-1,2,3,4-TETRAHYDROPYRIMIDO[1,2- A]QUINOLIN-11-IUM | A,B,C | 2W6T | 0.73 | |
PVE | (1S)-1-CARBOXY-5-[(3-CARBOXYPROPANOYL)AMINO]- 8,9-DIHYDROXY-1,2,3,4-TETRAHYDROPYRIMIDO[1,2- A]QUINOLIN-11-IUM | A,B,C | 2W16 | 0.73 | |
PVE | (1S)-1-CARBOXY-5-[(3-CARBOXYPROPANOYL)AMINO]- 8,9-DIHYDROXY-1,2,3,4-TETRAHYDROPYRIMIDO[1,2- A]QUINOLIN-11-IUM | A,B,C | 2W76 | 0.73 | |
PVE | (1S)-1-CARBOXY-5-[(3-CARBOXYPROPANOYL)AMINO]- 8,9-DIHYDROXY-1,2,3,4-TETRAHYDROPYRIMIDO[1,2- A]QUINOLIN-11-IUM | A,B,C | 2W78 | 0.73 | |
PVE | (1S)-1-CARBOXY-5-[(3-CARBOXYPROPANOYL)AMINO]- 8,9-DIHYDROXY-1,2,3,4-TETRAHYDROPYRIMIDO[1,2- A]QUINOLIN-11-IUM | A,B,C | 2W6U | 0.73 | |
PVE | (1S)-1-CARBOXY-5-[(3-CARBOXYPROPANOYL)AMINO]- 8,9-DIHYDROXY-1,2,3,4-TETRAHYDROPYRIMIDO[1,2- A]QUINOLIN-11-IUM | A,B,C | 2W77 | 0.73 | |
MR9 | 4-METHYL-3-({3-[2-(METHYLAMINO)PYRIMIDIN- 4-YL]PYRIDIN-2-YL}OXY)-N-[2-MORPHOLIN- 4-YL-5-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE | A,B | 2P4I | 0.73 | |
COP | N-(4-CARBOXY-4-{4-[(2,4-DIAMINO- PTERIDIN-6-YLMETHYL)-AMINO]-BENZOYLAMINO}- BUTYL)-PHTHALAMIC ACID | A | 1OHJ | 0.71 | |
COP | N-(4-CARBOXY-4-{4-[(2,4-DIAMINO- PTERIDIN-6-YLMETHYL)-AMINO]-BENZOYLAMINO}- BUTYL)-PHTHALAMIC ACID | A | 1OHK | 0.71 | |
DQU | 2,6-DIAMINO-3H-QUINAZOLIN-4-ONE | A | 1R5Y | 0.74 | |
DQU | 2,6-DIAMINO-3H-QUINAZOLIN-4-ONE | A | 1Q4W | 0.74 | |
UA4 | (2S)-6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN- 5-YL)-2-(3,5-DIFLUOROPHENYL)-4- (3-METHOXYPROPYL)-2-METHYL-2H-1,4- BENZOXAZIN-3(4H)-ONE | A,B | 2I4Q | 0.74 | |
APT | 2-AMINO-6-[(4-CARBOXY-PHENYLAMINO)- METHYL]-4-HYDROXY-PTERIDIN-1-IUM | A,B | 1QCJ | 0.74 | |
3B9 | N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin- 7-yl)-2-methylpropyl]-4-phenoxybenzamide | A | 3BAC | 0.73 | |
3B9 | N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin- 7-yl)-2-methylpropyl]-4-phenoxybenzamide | A | 3BA9 | 0.73 | |
L37 | A,B | 1DIG | 0.72 | ||
BI9 | 2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN- 4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)- N-METHYLBENZAMIDE | A | 2JKK | 0.71 | |
354 | N-[(S)-(4-{[(2-AMINO-4-HYDROXYQUINAZOLIN- 6-YL)(DIHYDROXY)-LAMBDA~4~-SULFANYL]AMINO}PHENYL)(HYDROXY)METHYL]- L-GLUTAMIC ACID | A,B | 1P4R | 0.74 | |
THH | N-[4-({[(6S)-2-AMINO-4-HYDROXY- 5-METHYL-5,6,7,8-TETRAHYDROPTERIDIN- 6-YL]METHYL}AMINO)BENZOYL]-L-GLUTAMIC ACID | A,B | 3DCJ | 0.76 | |
THH | N-[4-({[(6S)-2-AMINO-4-HYDROXY- 5-METHYL-5,6,7,8-TETRAHYDROPTERIDIN- 6-YL]METHYL}AMINO)BENZOYL]-L-GLUTAMIC ACID | A,B | 1WSV | 0.76 | |
Q4A | N-(1-benzylpiperidin-4-yl)-6,7- dimethoxy-2-(4-methyl-1,4-diazepan- 1-yl)quinazolin-4-amine | A,B | 3FPD | 0.71 | |
L34 | 4-(7-AMINO-9-HYDROXY-1-OXO-3,3A,4,5- TETRAHYDRO-2,5,6,8,9B-PENTAAZA- CYCLOPENTA[A]NAPHTHALEN-2-YL)-PHENYLCARBONYL- GLUTAMIC ACID | A,B | 1DIB | 0.74 | |
CMF | 3-CYCLOHEXYL-1-(2-MORPHOLIN-4-YL- 2-OXOETHYL)-2-PHENYL-1H-INDOLE- 6-CARBOXYLIC ACID | A | 2BRK | 0.71 | |
DTQ | 4-[3-HYDROXYANILINO]-6,7-DIMETHOXYQUINAZOLINE | A | 1DI8 | 0.71 | |
DFY | (5,6-DIPHENYL-FURO[2,3-D]PYRIMIDIN- 4-YLAMINO)-ACETIC | A | 2BRG | 0.72 | |
PRD | N6-(2,5-DIMETHOXY-BENZYL)-N6-METHYL- PYRIDO[2,3-D]PYRIMIDINE-2,4,6-TRIAMINE | A | 1BOZ | 0.72 | |
BZC | A | 1EFY | 0.7 | ||
IBI | N-{trans-4-[4-(cyclopropylmethyl)piperazin- 1-yl]cyclohexyl}-4-{[(7R)-7-ethyl- 5-methyl-8-(1-methylethyl)-6-oxo- 5,6,7,8-tetrahydropteridin-2-yl]amino}- 3-methoxybenzamide | A | 3FC2 | 0.7 | |
3IG | N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN- 5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO- 4H-1,4-BENZOXAZIN-4-YL]ETHYL}ACETAMIDE | A,B | 2G1R | 0.73 | |
A45 | 3-(5-AMINO-7-HYDROXY-[1,2,3]TRIAZOLO[4,5- D]PYRIMIDIN-2-YL)-BENZOIC ACID | A | 1RRI | 0.73 | |
DD1 | 5-{[1-(2-fluorobenzyl)piperidin- 4-yl]methoxy}quinazoline-2,4-diamine | A | 3BL7 | 0.73 | |
4IG | (2S)-6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN- 5-YL)-2-(3,5-DIFLUOROPHENYL)-4- (3-METHOXYPROPYL)-2H-1,4-BENZOXAZIN- 3(4H)-ONE | A,B | 2G1S | 0.75 | |
COG | 2,4-DIAMINO-6-[N-(2',5'-DIMETHOXYBENZYL)- N-METHYLAMINO]QUINAZOLINE | A | 1LY3 | 0.75 | |
DFW | N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN- 4-YL)GLYCINE | A | 2BRH | 0.7 | |
G96 | 4-[2-(4-amino-2,5-dihydro-1,2,5- oxadiazol-3-yl)-6-{[(2R)-2-amino- 3-phenylpropyl]oxy}-1-ethyl-1H- imidazo[4,5-c]pyridin-4-yl]-2-methylbut- 3-en-2-ol | A,B,C,D,E,F | 3E8C | 0.7 | |
G96 | 4-[2-(4-amino-2,5-dihydro-1,2,5- oxadiazol-3-yl)-6-{[(2R)-2-amino- 3-phenylpropyl]oxy}-1-ethyl-1H- imidazo[4,5-c]pyridin-4-yl]-2-methylbut- 3-en-2-ol | A,B | 3E88 | 0.7 | |
4RB | 4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2- b]pyridazin-3-yl)benzoic acid | A | 3BQR | 0.7 | |
HPM | N-{5-[(7-{[(2S)-2-HYDROXY-3-PIPERIDIN- 1-YLPROPYL]OXY}-6-METHOXYQUINAZOLIN- 4-YL)AMINO]PYRIMIDIN-2-YL}BENZAMIDE | A,B | 2C6E | 0.76 | |
KT3 | N-{4-4-(2,4-DIAMINO-6-OXO-1,6-DIHYDRO- PYRIMIDIN-5-YL)-1-(2,2,2-TRIFLUORO- 1,1-DIHYDROXY-ETHYL)-BUT-2-YL-BENZOYL}- GAMMA-GLUTAMYL-GAMMA-GLUTAMYL-GLUTAMIC ACID | A,B | 1RC1 | 0.7 | |
PFJ | 6,7-DIMETHOXY-4-[(3R)-3-(QUINOXALIN- 2-YLOXY)PYRROLIDIN-1-YL]QUINAZOLINE | A | 2OVY | 0.7 | |
L24 | [[[2-AMINO-5,6,7,8-TETRAHYDRO-4- HYDROXY-PYRIDO[2,3-D]PYRIMIDIN- 6-YL]-ETHYL]-PHENYL]-CARBONYL-GLUTAMIC ACID | A,B | 1DIA | 0.75 | |
PFH | 6,7-DIMETHOXY-4-[(3R)-3-(2-NAPHTHYLOXY)PYRROLIDIN- 1-YL]QUINAZOLINE | A | 2OVV | 0.71 | |
DOT | 3'ANTHRANILOYL-2'-DEOXY-ADENOSINE- 5'-TRIPHOSPHATE | A,B,C,D,E,F | 1LVC | 0.71 | |
PGJ | 2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)- 3-[2-(2-HYDROXYPHENOXY)PYRIMIDIN- 4-YL]ISOXAZOL-5(2H)-ONE | A | 1YW2 | 0.72 | |
5IG | 6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN- 5-YL)-4-(3-METHOXYPROPYL)-2,2-DIMETHYL- 2H-1,4-BENZOXAZIN-3(4H)-ONE | A,B | 2G1Y | 0.74 | |
G6G | N-{3-[(3-{4-[(4-methoxyphenyl)amino]- 1,3,5-triazin-2-yl}pyridin-2-yl)amino]- 4-methylphenyl}-4-[(4-methylpiperazin- 1-yl)methyl]benzamide | A,B | 3G6G | 0.71 | |
859 | 2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN- 4-YL}AMINO)BENZAMIDE | A,B | 2NO3 | 0.72 | |
447 | N-(4-{[6-methoxy-7-(3-morpholin- 4-ylpropoxy)quinazolin-4-yl]amino}phenyl)benzamide | A,B | 2VRX | 0.76 | |
T12 | 1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]- 1H-BENZIMIDAZOL-5-YL PIVALATE | A,B,C,D | 2NRU | 0.71 | |
NHR | 2-{4-[2-(2-AMINO-4-HYDROXY-QUINAZOLIN- 6-YL)-1-CARBOXY-ETHYL]-BENZOYLAMINO}- PENTANEDIOIC ACID | A,B | 1C3E | 0.8 | |
138 | A,B,C,D | 1JKX | 0.77 | ||
CL4 | N-{3-[5-(6-AMINO-PURIN-9-YL)-3,4- DIHYDROXY-TETRAHYDRO-FURAN-2-YL]- ALLYL}-2,3-DIHYDROXY-5-NITRO-BENZAMIDE | A | 1JR4 | 0.7 | |
MNT | 2'(3')-O-N-METHYLANTHRANILOYL-ADENOSINE- 5'-DIPHOSPHATE | A | 1LVK | 0.71 | |
AQZ | N-(3-{[7-METHOXY-6-(2-PYRROLIDIN- 1-YLETHOXY)QUINAZOLIN-4-YL]AMINO}- 4-METHYLPHENYL)-2-MORPHOLIN-4-YLISONICOTINAMIDE | A | 2BAK | 0.72 | |
PT1 | PTEROIC ACID | A,B | 1TX0 | 0.76 | |
PT1 | PTEROIC ACID | A | 1BR6 | 0.76 | |
PT1 | PTEROIC ACID | A,B | 1HWP | 0.76 | |
R78 | 4-{[(7R)-8-cyclopentyl-7-ethyl- 5-methyl-6-oxo-5,6,7,8-tetrahydropteridin- 2-yl]amino}-3-methoxy-N-(1-methylpiperidin- 4-yl)benzamide | A | 2RKU | 0.72 | |
MOT | N-[4-[(2,4-DIAMINOFURO[2,3D]PYRIMIDIN- 5-YL)METHYL]METHYLAMINO]-BENZOYL]- L-GLUTAMATE | A | 1HFR | 0.72 | |
MOT | N-[4-[(2,4-DIAMINOFURO[2,3D]PYRIMIDIN- 5-YL)METHYL]METHYLAMINO]-BENZOYL]- L-GLUTAMATE | A | 1DAJ | 0.72 | |
MOT | N-[4-[(2,4-DIAMINOFURO[2,3D]PYRIMIDIN- 5-YL)METHYL]METHYLAMINO]-BENZOYL]- L-GLUTAMATE | A | 1HFQ | 0.72 | |
MOT | N-[4-[(2,4-DIAMINOFURO[2,3D]PYRIMIDIN- 5-YL)METHYL]METHYLAMINO]-BENZOYL]- L-GLUTAMATE | A | 1HFP | 0.72 | |
ONA | A,C | 2GVZ | 0.72 | ||
P40 | N-cyclopropyl-4-methyl-3-{2-[(2- morpholin-4-ylethyl)amino]quinazolin- 6-yl}benzamide | A | 3DT1 | 0.7 | |
MTX | METHOTREXATE | A,B | 1DRB | 0.7 | |
MTX | METHOTREXATE | A,B,C,D | 2C7V | 0.7 | |
MTX | METHOTREXATE | A | 1U70 | 0.7 | |
MTX | METHOTREXATE | A,B,C,D | 1MXF | 0.7 | |
MTX | METHOTREXATE | A | 2QK8 | 0.7 | |
MTX | METHOTREXATE | A,B | 1RB3 | 0.7 | |
MTX | METHOTREXATE | A,B | 1DHJ | 0.7 | |
MTX | METHOTREXATE | A | 3DAU | 0.7 | |
MTX | METHOTREXATE | A | 1U72 | 0.7 | |
MTX | METHOTREXATE | A,B | 2DRC | 0.7 | |
MTX | METHOTREXATE | A,B | 1D1G | 0.7 | |
MTX | METHOTREXATE | A,B | 1DDR | 0.7 | |
MTX | METHOTREXATE | A,B | 1E7W | 0.7 | |
MTX | METHOTREXATE | A | 1RX3 | 0.7 | |
MTX | METHOTREXATE | A | 3DFR | 0.7 | |
MTX | METHOTREXATE | A,B,C,D | 1P33 | 0.7 | |
MTX | METHOTREXATE | A | 3DAT | 0.7 | |
MTX | METHOTREXATE | A,B | 1DHI | 0.7 | |
MTX | METHOTREXATE | A,B | 1TDR | 0.7 | |
MTX | METHOTREXATE | A,B | 1DRA | 0.7 | |
MTX | METHOTREXATE | A | 3EIG | 0.7 | |
MTX | METHOTREXATE | A | 3CD2 | 0.7 | |
MTX | METHOTREXATE | A | 1AO8 | 0.7 | |
MTX | METHOTREXATE | A | 1DF7 | 0.7 | |
MTX | METHOTREXATE | A | 1DLS | 0.7 | |
MTX | METHOTREXATE | A | 1RG7 | 0.7 | |
MTX | METHOTREXATE | A | 1RH3 | 0.7 | |
MTX | METHOTREXATE | A,B | 4DFR | 0.7 | |
MTX | METHOTREXATE | A | 1RA3 | 0.7 | |
MTX | METHOTREXATE | A,B | 1DDS | 0.7 | |
MTX | METHOTREXATE | A | 1DRE | 0.7 | |
MTX | METHOTREXATE | A,B | 1AXW | 0.7 | |
MTX | METHOTREXATE | A | 3CL9 | 0.7 | |
MTX | METHOTREXATE | A,B | 3DRC | 0.7 | |
MTX | METHOTREXATE | A,B,C,D,E | 2OIP | 0.7 | |
Q22 | (4aS)-5-[(2,4-diaminopteridin-6- yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin- 8-ol | A | 3D80 | 0.7 |